HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New proton therapy may cut side effects for head and neck cancer patients
Disease control OngoingThis study compares two types of radiation therapy after surgery for head and neck cancer: proton therapy (IMPT) and standard X-ray radiation (IMRT). The goal is to see if proton therapy controls cancer just as well while causing fewer side effects. About 174 adults with newly di…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 04:37 UTC
-
New drug cocktail targets tough head and neck tumors
Disease control OngoingThis early-phase study tests a new drug called berzosertib (M6620) alongside standard chemotherapy (cisplatin) and radiation for people with advanced head and neck cancer that has spread to nearby tissues or lymph nodes. The main goal is to find the safest dose and understand sid…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for head and neck cancer: drug plus radiation shows promise in early trial
Symptom relief OngoingThis early-phase study tests whether combining the drug tolinapant with radiation therapy is safe and doable for people with head and neck cancer that hasn't been treated yet and has spread locally. Participants are those who can't take the standard chemo drug cisplatin. The goal…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 17, 2026 04:38 UTC